Fundamentals ADMA (NASDAQ) - ADMA Biologics Inc

VR Fundamental Rating -2.74

VR Piotroski Score 3.00
Altman-Z Score 1.88
Tobins Q Ratio -
Tax Rate -88.02%
Free-Cash-Flow Yield -6.77%
Free-Cash-Flow Margin -33.66%
Net Margin -26.22%
Gross Margin 26.45%
Current Ratio 7.19
Debt / Equity 1.00
Debt / EBITDA -6.68
Debt / Free-Cash Flow -2.37
Interest Expense / Debt 15.15%
RoE Return on Equity -32.74%
RoCE Return on Cap. Employed -8.34%
RoA Return on Assets -13.99%
RoIC Return on Inv. Cap. -33.07%
Analysts Rating 4.67
Analysts Target Price
(is above last close by
5.13 USD
26.7%)

VR Piotroski 3.00

1 - No: Net Income TTM (-47.7m) > 10m and > 3% of Revenue TTM (3% = 5.5m)
2 - No: FCF TTM (-61.2m) > 1m and > FCF prev (98%) (-116.6m)
3 - No: RoA TTM -13.99% (Net Income TTM -47.7m / Total Assets 340.8m) >3% and > RoA prev (98%) -22.79% (-71.6m / 308.0m)
4 - No: Total Cash from Operating Activities TTM -48.2m > 1m and > Net Income TTM -47.7m
5 - Error: Net Debt/EBITDA cant be calculated
6 - Yes: Current Ratio 7.19 (Total Current Assets 264.1m / Total Current Liabilities 0.0m) >= 1 and > Current Ratio prev (98%) 6.87 (208.7m / 30.4m)
7 - No: Shares Outstanding last quarter 221.9m < quarter 12m ago 195.9m
8 - Yes: Gross Margin 26.45% (Total Revenue 181.9m - Cost Of Revenue 133.8m / Total Revenue) > 20% and > Gross Margin prev (98%) 6.84%
9 - Yes: Asset Turnover 0.53 (Total Revenue 181.9m / Total Assets 340.8m) > Asset Turnover prev (98%) 0.3 (94.0m / 308.0m)
10 - No: Interest Coverage Ratio None (EBITDA -21.7m / Interest Expense 22.0m) > 5

Altman-Z 1.88

A = 0.667 = (Total Current Assets 264.1m - Total Current Liabilities 36.7m) / Total Assets 340.8m
B = -1.423 = Retained Earnings -484.8m / Total Assets 340.8m
C = -0.074 = EBIT TTM -25.4m / Total Assets 340.8m
D = 4.636 = Market Cap 904.7m / Total Liabilities 195.1m
E = 0.534 = Revenue TTM 181.9m / Total Assets 340.8m
1.879 = (1.2 * A) + (1.4 * B) + (3.3 * C) + (0.6 * D) + (1.0 * E)

Current Fundamental Values

Market Cap = 904.7m USD
Market Cap in USD = 904.7m (904.7m USD * 1 USDUSD)
Revenue TTM = 181.9m
Debt = 145.3m (short 0.956045m + long 144.30093m) last quarter
CCE = unknown 'cashAndEquivalents'
Enterprise Value = 1049.9m (Market Cap 904.7m + Debt 145.3m - CCE 0m)
Net Debt = 145.3 (145.3m Debt - 0m Cash and Cash Equilavents)
EBITDA = -21.7m (TTM)
FCF Yield = -6.77% (FCF TTM -61.2m / Market Cap 904.7m)
FCF Margin = -33.66% (FCF TTM -61.2m / Revenue TTM 181.9m)
Net Margin = -26.22% (Net Income TTM -47.7m / Revenue TTM 181.9m)
Gross Margin = 26.45% ((Revenue TTM 181.9m - Cost of Revenue TTM 133.8m) / Revenue TTM 181.9m)
Tobins Q-Ratio = unknown (Market Cap 904.6511 / Book Value Of Equity False)
Interest Expense / Debt = 15.15% (Interest Expense TTM 22.01m / Debt 145.3m)
Interest Coverage Ratio = None (EbitDA TTM -21.74m) / Interest Expense TTM 22.01m)
Taxrate = -88.02% last quarter (Income Tax Expense 5.98m / Income Before Tax -6.79m)
nopat = unkown (Taxrate is negative or null: -0.88)
Current Ratio = 7.19 (Total Current Assets 264.1m / Total Current Liabilities 36.73m)
Debt / Equity = 1.00 (Debt 145m / last Quarter total Stockholder Equity 145m)
Debt / EBITDA = -6.68 (Debt 145m - Cash and Cash Equivalents 0m / EBITDA -21m)
Debt / FCF = -2.37 (Debt 145m / FCF TTM -61m)
RoA = -13.99%
RoE = -32.74% (Net Income TTM -47m / Total Stockholder Equity 145m)
RoCE = -8.34% (Ebit TTM -25.36m / x)
RoIC = -33.07% (Ebit TTM -25.36m / (Total Assets 340.8m - Total Current Assets 264.1m) )
WACC = 11.43% ((Market Cap / EV) * CAPM 0.09) + (Debt / EV) * Interest Expense on Debt * (1 - Taxrate)
Shares Correlation 10y: 100.00 - Cagr: 36.54% (36.54)
EPS Kendall: 88.04 - EPS Cagr: 11.50% (10.12)
Rev Kendall: 90.31 - Rev Cagr: 13.39% (12.09)